As Filed with the Securities and Exchange Commission on August 27, 1999
Registration No. 333-78115
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
---------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-1
REGISTRATION STATEMENT
Under
THE SECURITIES ACT OF 1933
---------------
SHAMAN PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware 94-3095806
(State or other jurisdiction of (I.R.S. Employer
Incorporation or organization) Identification Number)
213 East Grand Avenue
South San Francisco, California 94080-4812
(650) 952-7070
(Address, including zip code, and telephone number, including area code, of
the Registrant's principal executive offices)
LISA A. CONTE
President and Chief Executive Officer
Shaman Pharmaceuticals, Inc.
213 East Grand Avenue
South San Francisco, California 94080-4812
(650) 952-7070
(Name, address, including zip code, and telephone number, including area
code, of agent for service of process)
Copies to:
Donald C. Reinke
Bruce P. Johnson
Bay Venture Counsel, LLP
1999 Harrison Street, Suite 1300
Oakland, California 94612
510-273-8750
Approximate date of commencement of proposed sale to the public:
Completed.
---------------
If any of the Securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities
Act of 1933, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
================================================================================
<PAGE>
The Registrant hereby amends this Registration Statement on Form S-1
(Registration No. 333-78115) ("Registration Statement"), to deregister and
remove from registration 282,851 shares of the Registrant's Series R Convertible
Preferred Stock, and all shares of common stock issuable upon conversion
thereof, remaining unsold at the conclusion of the offering described in the
Registration Statement.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant
has duly caused this Post-Effective Amendment No. 1 to the Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of South San Francisco, State of California, on August
27, 1999.
SHAMAN PHARMACEUTICALS, INC.
By: /s/ Lisa A. Conte
------------------
Lisa A. Conte
Pursuant to the requirements of the Securities Act of 1933, this
Post-Effective Amendment No. 1 to the Registration Statement has been signed by
the following persons in the capacities and on the dates indicated:
Name Title Date
- -------------------------- ------------------------------- -------------
/s/ Lisa A. Conte
- -------------------------- Director, President, Chief August 27, 1999
Lisa A. Conte Executive Officer and Chief
Financial Officer, (Principal
Executive Officer and Principal
Financial and Accounting Officer)
/s/ G. Kirk Raab*
- -------------------------- Chairman of the Board August 27, 1999
G. Kirk Raab
/s/ Adrian D.P. Bellamy*
- -------------------------- Director August 27, 1999
Adrian D.P. Bellamy
/s/ Jeffrey Berg*
- -------------------------- Director August 27, 1999
Jeffrey Berg
/s/ Herbert H. McDade, Jr.*
- -------------------------- Director August 27, 1999
Herbert H. McDade, Jr.
/s/ M. David Titus*
- -------------------------- Director August 27, 1999
M. David Titus
- -------------------------- Director August __, 1999
Loren D. Israelsen
*By:/s/ Lisa Conte
--------------------------
Lisa Conte, Attorney-in-fact
